- Home
- NTWK vs CRIS Comparison
NTWK vs CRIS Comparison
Compare NTWK & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTWK
- CRIS
- Stock Information
- Founded
- NTWK 1997
- CRIS 2000
- Country
- NTWK United States
- CRIS United States
- Employees
- NTWK N/A
- CRIS N/A
- Industry
- NTWK Computer Software: Prepackaged Software
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTWK Technology
- CRIS Health Care
- Exchange
- NTWK Nasdaq
- CRIS Nasdaq
- Market Cap
- NTWK 31.1M
- CRIS 31.2M
- IPO Year
- NTWK 1998
- CRIS 2000
- Fundamental
- Price
- NTWK $2.66
- CRIS $3.08
- Analyst Decision
- NTWK
- CRIS Strong Buy
- Analyst Count
- NTWK 0
- CRIS 3
- Target Price
- NTWK N/A
- CRIS $23.00
- AVG Volume (30 Days)
- NTWK 21.4K
- CRIS 74.2K
- Earning Date
- NTWK 02-11-2025
- CRIS 02-06-2025
- Dividend Yield
- NTWK N/A
- CRIS N/A
- EPS Growth
- NTWK N/A
- CRIS N/A
- EPS
- NTWK 0.06
- CRIS N/A
- Revenue
- NTWK $61,749,408.00
- CRIS $10,259,000.00
- Revenue This Year
- NTWK N/A
- CRIS N/A
- Revenue Next Year
- NTWK N/A
- CRIS N/A
- P/E Ratio
- NTWK $42.31
- CRIS N/A
- Revenue Growth
- NTWK 14.50
- CRIS 0.44
- 52 Week Low
- NTWK $1.99
- CRIS $3.05
- 52 Week High
- NTWK $3.34
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- NTWK 39.20
- CRIS 27.27
- Support Level
- NTWK $2.65
- CRIS $3.75
- Resistance Level
- NTWK $2.78
- CRIS $4.25
- Average True Range (ATR)
- NTWK 0.11
- CRIS 0.33
- MACD
- NTWK 0.00
- CRIS -0.07
- Stochastic Oscillator
- NTWK 33.33
- CRIS 2.14
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.